Portal


Dr Khasha Ghaffarzadeh
Dr Khasha Ghaffarzadeh
IDTechEx
+44 (0)1223 812300
Email Analyst
BreathDX
 

BreathDX

BreathDX BreathDX has developed a technology for analysing ammonia concentrations in breath. This is useful for long term monitoring in kidney and liver diseases. David Pugh spoke to CEO Prof Tony Killard about their recent success. History BreathDX was founded in 2015 by Tony Killard and Dara Fitzgerald based on research carried out over a period of 10 years at Dublin City University. After receiving funding from Enterprise Ireland. The company began in looking at polyaniline gas sensors for industrial applications but found that they were better suited to breath analysis. The company is currently running studies at four hospitals in England for research purposes. BreathDX